This study has shown that cancer-associated fibroblast substances can activate HMGB1 expression and secretion by cancer cells, which can then be released into the tumor microenvironment and the HMGB1-RAGE interaction promotes breast cancer progression and drug resistance [3]. The gene discussed is AGER; the disease is neoplasm.